Pathology Doctors in Ridgewood, NJ Accepting Medicare

6 Pathology doctors found. Showing 1 - 6

Elizabeth Eapen, M.D. Pathology - Anatomic Pathology Medicare: Accepting Medicare Assignments Practice Location: 223 North Van Dien Avenue, Department Of Pathology, Ridgewood, NJ 07450 Phone: 201-447-8242

Dr. Metin Taskin, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 223 N Van Dien Ave, Valley Hospital-pathology, Ridgewood, NJ 07450 Phone: 201-447-8242    Fax: 201-447-8657

Dr. Arthur Andrew Christiano, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 223 N Van Dien Ave, Department Of Pathology, Ridgewood, NJ 07450 Phone: 201-447-8242    Fax: 201-447-8657

Dr. Michael H Reilly, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 223 N Van Dien Ave, Ridgewood, NJ 07450 Phone: 201-447-8242    Fax: 201-447-8657

Dr. Robert M Mazziotta, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 223 N Van Dien Ave, Ridgewood, NJ 07450 Phone: 201-447-8242

Tingliang Shen, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 132 Kenilworth Rd, Ridgewood, NJ 07450 Phone: 610-213-4747

News Archive

Report on mental health outcomes of former child soldiers in Sierra Leone

The Child Soldiers Global Report 20081 estimates that more than 300,000 children are engaged as soldiers around the globe, and more children are recruited every year in ongoing and new conflicts. Although a number of multinational coalitions are aligned to stop the recruitment of child soldiers, some countries persist in not only the recruitment of children but also in exposing children to both the psychological and physical dangers associated with combat.

Absence of anti-tumor protein may cause resistance to EGFR-targeting therapies

The absence of a protein that works to prevent tumor formation may explain why some patients are resistant to a common cancer therapy, according to Penn State College of Medicine researchers.

Scientists identify molecules that may be key to drug resistance in estrogen-driven breast cancers

Three-quarters of all breast cancer tumors are driven by the hormone estrogen. These tumors are frequently treated with drugs to suppress estrogen receptor activity, but unfortunately, at least half of patients do not respond to these treatments, leaving them with drug-resistant tumors and few options.

Researchers develop new lab test for diagnosing preeclampsia

In as many as 8 percent of pregnancies worldwide, women who seem fine for months develop preeclampsia, a serious complication causing symptoms including high blood pressure, severe swelling, and problems with placental development. The untreatable and unpredictable condition, with no known cause, often requires premature delivery, and can sometimes kill the mother and the fetus.

Read more Medical News

› Verified 7 days ago